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Heterotropic Cooperativity in Cytochrome P450 eryF
Kerry Guyer and Jeffrey Grinstead
Department of Chemistry, University of Puget Sound

Background

NMR-PRE Experiments

Cytochromes P450 are a family of enzymes that metabolize most
chemicals that enter the body, including drugs and environmental
toxins.[1] These enzymes tend to be extremely unspecific and
flexible, meaning they can often bind to various types of molecules
and even multiple substrates at a time.[2] Interestingly, it is possible
for the binding of one molecule in the active site to influence the
binding and subsequent catalysis of a second molecule – a
phenomenon known as cooperativity. This is responsible for drugdrug interactions, where the effects of one drug (the substrate) are
altered by another drug (an effector), often leading to harmful
outcomes like toxicity.[3]
The process of cooperativity is poorly understood. Studies using
the bacterial model enzyme eryF suggest that there are two distinct
binding sites inside a larger binding pocket, and that while a
substrate may bind to only one of these sites, effector molecules can
bind to either.[4,5] The present experiment had three primary goals:
(1) to reproduce literature data for the affinity of 4-CPI and 9-AP for
P450 eryF, (2) to test how effectors (such as 9-AP) influence
substrate binding, and (3) to ultimately develop a more precise
model of the eryF active site.

Methods
Absorbance difference titrations were used to determine enzyme
affinity for substrate and effector molecules. NMR paramagnetic
relaxation experiments acquired data for distance measurements,
which were then entered into the molecular docking software
HADDOCK to model the structure of the ligand-protein complex.
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Figure 2 Example of proton relaxation curve. Data points (triangles and
diamonds) show peak intensity after a given tau interval and are fit to a
exponential model (curve) using the equation:

I  I max * (1  2 * e(  / T 1) )

Figure 3 T1 relaxation time as a function of enzyme concentration. As the
concentration of enzyme increases, the T1 value decreases, representing the
larger fraction of 4-CPI being affected by the paramagnetic iron in the eryF
active site.

where Imax describes the horizontal asymptote, τ is the relaxation delay, and
T1 is a fitting parameter unique to the proton.

Figure 4 Stacked plot of NMR relaxation spectra for free 4-CPI. Tau interval
increases from bottom to top, where the lowest spectrum shows τ = 0.1 s and
the top shows τ = 12 s. Relaxation experiments used the sequence 180º-τ90º-detect, with 20 seconds relaxation delay and τ values of 12, 10, 6, 3, 2, 1,
0.75, 0.5, 0.3, 0.2, and 0.1 seconds. These experiments took 16 scans at 28.5º C
unless otherwise indicated.

• The rate at which a nucleus relaxes depends on its environment, where closer proximity to a
paramagnetic center speeds relaxation. With a paramagnetic iron in the eryF active site, protons on
bound 4-CPI re-equilibrate with the surrounding magnetic field more quickly than do the protons
on free ligand.
• Because relaxation rates represent an average of all protons in solution, increasing the fraction of
ligand bound decreases T1 values, as shown in Figure 3. This may also be explained by the equation
shown by Figure 5, where adding enzyme increases alpha.
• T1 values of the protons on free 4-CPI were all between 2 and 2.5 seconds, except for that of the
peak furthest downfield, which relaxed more slowly and gave a T1 near 4.3 seconds.

Molecular Modeling
• Adding ligand causes absorbance
to decrease at 417 nm and to
increase at 437 nm in a manner
proportional to the concentration of
enzyme-ligand complex.
• Figure 1A and B show absorbance
difference (A437 - A417) as a function
of ligand concentration. Titration
data were consistent with reported
affinity values.
• With 9-AP-bound eryF used as a
baseline, small concentrations of 9AP do not change the apparent
affinity of 4-CPI (Figure 1D, E).
• In contrast, a saturating amount
of 9-AP (that fills both binding sites)
prevents 4-CPI from further altering
solution absorbance (Figure 1F).
Figure 1 Absorbance difference spectra. EryF (3
uM) was titrated separately with 4-CPI (from 0 to
750 uM) and 9-AP (from 0 to 20 uM) [A, B], then
presaturated with 9-AP, baselined, and titrated with
4-CPI as done previously [C through F].
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Figure 5 The crystal structure of CYP2B4 in complex with 4-CPI with Fe-C distances
shown.[6] NMR T1 results were converted to distances using a simplified form of the
Solomon-Bloembergen equation[7]:
1
9.87 1016 S ( S  1)

( c )
6
T 1p
r
(α = fraction of ligand bound out of the total ligand concentration, r = distance from proton
to iron, τc = 3  10 10 seconds , and S = spin state of the iron, which in this case is ½)

Ligand-protein complexes were modeled using distance measurements
and the molecular docking program HADDOCK, producing images such
as that shown in Figure 5. Preliminary trials have successfully generated
ligand-protein models, showing that our protocols work and docking is
possible.

Conclusions
• Literature ligand binding affinities were reproduced, with KD of 4-CPI = 26.8 uM and S50 of 9-AP = 5.8 uM.
• Pre-saturating eryF with low concentrations of 9-AP, so that only the first site is occupied, does not affect 4-CPI binding
affinity. Therefore, the first equivalent of 9-AP must bind somewhere other than near the heme. However, filling the
second 9-AP binding site induces the same absorbance change as does 4-CPI binding, showing that the second equivalent of
9-AP must bind in the same location and coordinate to the heme iron.
• The 4-CPI protons relax differently depending on whether the ligand is enzyme-bound or free in solution, and this change
in T1 is proportional to the fraction of ligand bound.
• This and temperature data (not shown) show that the change in relaxation is due to the influence of the heme, making
distance measurements possible.
• Reducing the protein (Fe3+  Fe2+) eliminates the paramagnetic influence on T1 values and allows calculation of ligandiron distances.

Future Directions

The T1 values of 4-CPI bound to reduced eryF did not match those obtained of free ligand, contrary to our expectation.
Future experiments will seek to improve reproducibility of the T1 data, especially in reduced samples, by adopting one or
more of the following changes:
• Use a different reducing agent
• Flushing samples with CO
• Use a different ligand that would convert the iron to a high-spin complex (S = 5/2), which would increase the
paramagnetic effect and possibly make T1 changes easier to detect

